Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Ltd (CLGN)
Price$3.54Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4M | $515,000 | $11.0M | $299,000 | $15.6M | $6.1M | $2.3M | $5.0M | $463,000 | — | — |
| Gross profit | $1.5M | −$1.1M | $9.0M | −$101,000 | $13.6M | $3.1M | $439,000 | $3.4M | $415,000 | — | — |
| Gross margin | 64.78% | −215.53% | 81.83% | −33.78% | 87.18% | 51.08% | 18.94% | 66.91% | 89.63% | — | — |
| Research & development | $8.2M | $10.5M | $10.5M | $10.3M | $7.6M | $4.1M | $4.4M | $3.9M | $584,000 | — | — |
| Operating expenses | $13.0M | $16.1M | $16.5M | $17.0M | $13.6M | $34,000 | $3.3M | $2.2M | $6.4M | — | — |
| Operating income | −$11.5M | −$17.3M | −$7.5M | −$17.1M | $65,000 | −$5.6M | −$7.6M | −$4.2M | −$6.0M | — | — |
| Operating margin | −484.31% | −3,349.71% | −68.55% | −5,718.06% | 0.42% | −91.23% | −329.21% | −84.66% | −1,286.61% | — | — |
| EBITDA | −$10.6M | −$16.2M | −$6.4M | −$16.0M | $838,000 | −$4.9M | −$7.1M | −$3.9M | −$5.7M | — | — |
| EBITDA margin | −445.85% | −3,148.16% | −58.49% | −5,358.19% | 5.36% | −80.48% | −305.95% | −77.84% | −1,236.93% | — | — |
| Net income | −$11.5M | −$16.6M | −$7.0M | −$16.9M | $237,000 | −$5.8M | −$11.2M | −$6.2M | −$6.1M | — | — |
| Net profit margin | −484.56% | −3,225.05% | −64.05% | −5,660.54% | 1.52% | −94.09% | −481.62% | −124.63% | −1,306.91% | — | — |
| Basic EPSper basic share | -$0.94 | -$1.45 | -$0.62 | -$1.53 | $0.02 | -$0.84 | -$2.23 | $1.43 | $2.27 | — | — |
| Diluted EPSper diluted share | -$0.94 | -$1.45 | -$0.62 | -$1.53 | $0.02 | -$0.84 | -$2.23 | $1.43 | $2.27 | — | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
PINNACLE ASSOCIATES LTD | 731.66K |
VILLERE ST DENIS J & CO LLC | 606.4K |
BROWN ADVISORY INC | 104.73K |
RENAISSANCE TECHNOLOGIES LLC | 61.5K |
Pathstone Holdings, LLC | 57K |
CITADEL ADVISORS LLC | 53.7K |
Tal Yehiel | 31.14K |
Legacy Wealth Managment, LLC/ID | 23.18K |
WATERS PARKERSON & CO., LLC | 13.25K |
XTX Topco Ltd | 13.08K |
FNY Investment Advisers, LLC | 5.25K |
Bensimon Philippe | 2K |
UBS Group AG | 1.04K |
OSAIC HOLDINGS, INC. | 345 |
SBI Securities Co., Ltd. | 200 |
Strive Financial Group ,LLC | 169 |
MORGAN STANLEY | 1 |
Evans Hugh M | — |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data